Ikarian Capital LLC

6 employees

We leverage our co-founder’s medical and financial background to invest both long and short in biotechnology and pharmaceuticals.

Investor insights

Sectors invested in

Biotechnology4

Health Care4

Therapeutics2

Pharmaceutical2

Rare disease and primary immunodeficiencies1

Scope of applicability extensive; for use in many diseases1

Program a patient's cells to produce antibodies1

Patient convenience; eliminates frequent needle injections1

enzymes1

Life Science1

Enables an entire new set of treatments options for patients1

conditionally active biologics1

protein evolution and engineering1

antibody evolution and engineering1

Medical1

development of novel cancer immunotherapies1

Biopharma1

Clinical Trials1

Funding rounds participated in

$55M sweet spot round size

Most of their 7 investments are in rounds between $30M and $75M

Basic info

Industry

financial services

Sectors

Biotechnology

Financial Services

Biotech

Hedge Fund

Pharmaceuticals

Date founded

2015

Investments made

BioAtla, Inc. raised $75M on September 29, 2021

Investors: Great Point Partners, Monashee Investment Management LLC, Hudson Bay Capital Management LP, Soleus Capital Management, L.P., Pappas Capital and Ikarian Capital LLC

Undisclosed raised $30M on September 3, 2021

Investors: Innogest Capital, Longview Ventures, RTW Investments, LP, Altium Capital, Sio Capital Management LLC, Surveyor Capital, Acorn Bioventures, Affinity Asset Advisors and Ikarian Capital LLC

ValenzaBio raised $79M on April 8, 2021

Investors: Pierre Fabre, Surveyor Capital and Ikarian Capital LLC

X4 Pharmaceuticals raised $55M on March 19, 2021

Investors: Lincoln Park Capital, LLC, Abingworth, OrbiMed Advisors, Driehaus Capital Management LLC, Monashee Investment Management LLC, Altium Capital, Sio Capital Management LLC and Ikarian Capital LLC

Undisclosed raised $34M on December 15, 2020

Investors: The Invus Group, Altium Capital and Ikarian Capital LLC

Undisclosed raised $90M on December 11, 2020

Investors: Suvretta Capital Management LLC, Aspire Capital Partners, LLC, Perceptive Advisors, RA Capital Management, L.P. and Ikarian Capital LLC

Immusoft Corporation raised $4.5M on September 25, 2020

Investors: Breakout Ventures and Ikarian Capital LLC